• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Hadean Ventures (NO)

Hadean Ventures is a European life science fund manager that invests in life science companies across Europe with a particular focus on the Nordic region. Hadean Ventures is managing funds backed by leading private and institutional investors including Saminvest and Argentum. Hadean Ventures has offices in Oslo and Stockholm and collaborates with world-class academic institutions and start-up hubs across the region. *

 

	Start	2016-05-03 existent
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director)
	Person 2	Franklin, Roger (Hadean Ventures 202007 Partner)
	Region	Oslo
	Country	Norway
	Street	1 Dronningen
	City	0287 Oslo
	Tel	+47-24-115722
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for �About Section�: Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo.
		Record changed: 2021-04-05

Advertisement

More documents for Hadean Ventures (NO)

• [1] Step Pharma S.A.S.. (3/24/21). "Press Release: Step Pharma Raises EUR35 Million in Series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies". Archamps....
• [2] Gesynta Pharma AB. (7/7/20). "Press Release: Gesynta Raises SEK 190 Million in Round Led by Hadean Ventures to Accelerate Development of First-in-class mPGES-1 Inhibitor GS-248 for Systemic Sclerosis". Stockholm....
• [3] Neuro Event Labs Oy. (4/8/20). "Press Release: Neuro Event Labs Closes €3.9M Series A Round to Become the Standard for Epilepsy Diagnostics"....
• [4] Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo....
• [5] Hadean Ventures. (12/18/17). "Press Release: Hadean Ventures Launches New Fund to Leverage Untapped Potential of European Life Science Start-ups". Oslo & Stockholm....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.